HKSE · 1093.HK
CSPC Pharmaceutical Group Limited
HK$7.82-HK$0.22 (-2.74%)
CSPC Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.65% below the high.
Loading market information…
HKSE · 2005.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:40 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
SSY Group Limited’s quoted price sits in the lower half of its reported 52-week range, 18.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
SSY Group Limited’s forward annual dividend is HK$0.11 per share, paid semi-annual. The forward yield is 4.26% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
SSY Group Limited’s next earnings report is currently expected on Mar 26, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow SSY Group Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC and upright soft bag, PP plastic bottle, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:56 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| HK$0.19 |
| HK$3.03B-62.63% vs estimate |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$7.82-HK$0.22 (-2.74%)
CSPC Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.65% below the high.
HK$4.82-HK$0.03 (-0.62%)
Sino Biopharmaceutical Limited’s quoted price sits in the lower half of its reported 52-week range, 35.56% below the high.
HK$4.63+HK$0.13 (+2.89%)
China Resources Pharmaceutical Group Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.17% below the high.
HK$10.14-HK$0.24 (-2.31%)
Simcere Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 29.49% below the high.
HK$9.83-HK$0.08 (-0.81%)
China Medical System Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 36.63% below the high.
HK$4.32HK$0.00 (0.0%)
Grand Pharmaceutical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 51.35% below the high.
HK$6.86+HK$0.01 (+0.07%)
The United Laboratories International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
HK$0.73+HK$0.02 (+2.11%)
Sihuan Pharmaceutical Holdings Group Ltd.’s quoted price sits in the lower half of its reported 52-week range, 59.5% below the high.
